Gardiner Healthcare Acquisitions, a blank check company targeting high-growth healthcare businesses, raised $75 million by offering 7.5 million units at $10. Each unit consists of one share of common stock and one warrant, exercisable at $11.50.
The company is led by CEO and Chairman Marc Pelletier, co-founder and Managing Member of co-sponsor Gardiner Founder, and the founder and former CEO, CFO, and CSO of clinical-stage drug developer Aeromics. The company is also co-sponsored by Chardan.
Gardiner Healthcare Acquisitions plans to target high-growth healthcare businesses, particularly those in the North American or European life sciences and medical technology sectors, with a specific focus on small and large molecule therapeutics.
Gardiner Healthcare Acquisitions plans to list on the Nasdaq under the symbol GDNRU. Chardan Capital Markets acted as sole bookrunner on the deal.
